Royal Bank of Canada
CRBU icon

Royal Bank of Canada’s Caribou Biosciences CRBU Stock Holding History

Royal Bank of Canada’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Sell
2,462
-12,412
-83% -$21.3K ﹤0.01% 6405
2025
Q4 		$24K Sell
14,874
-559,393
-97% -$1.17M ﹤0.01% 5935
2025
Q3 		$1.34M Sell
574,267
-24,964
-4% -$47.1K ﹤0.01% 3741
2025
Q2 		$754K Buy
599,231
+574,491
+2,322% +$565K ﹤0.01% 4144
2025
Q1 		$23K Sell
24,740
-12,614
-34% -$16.4K ﹤0.01% 5864
2024
Q4 		$59K Sell
37,354
-1,331
-3% -$2.68K ﹤0.01% 5602
2024
Q3 		$76K Sell
38,685
-4,124
-10% -$8.45K ﹤0.01% 5505
2024
Q2 		$71K Buy
42,809
+4,052
+10% +$12.9K ﹤0.01% 5474
2024
Q1 		$199K Sell
38,757
-243,180
-86% -$1.5M ﹤0.01% 4694
2023
Q4 		$1.62M Buy
281,937
+249,997
+783% +$1.24M ﹤0.01% 3244
2023
Q3 		$153K Buy
31,940
+23,834
+294% +$148K ﹤0.01% 5040
2023
Q2 		$34K Buy
8,106
+2,785
+52% +$12.5K ﹤0.01% 5951
2023
Q1 		$29K Sell
5,321
-3,187
-37% -$19.9K ﹤0.01% 5881
2022
Q4 		$54K Buy
8,508
+5,655
+198% +$50.3K ﹤0.01% 5829
2022
Q3 		$30K Buy
2,853
+379
+15% +$3.53K ﹤0.01% 5973
2022
Q2 		$14K Sell
2,474
-2,250
-48% -$17.2K ﹤0.01% 6240
2022
Q1 		$44K Buy
4,724
+966
+26% +$10.2K ﹤0.01% 6176
2021
Q4 		$58K Buy
3,758
+1,000
+36% +$19.4K ﹤0.01% 6285
2021
Q3 		$66K Buy
+2,758
New +$67.4K ﹤0.01% 5990

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royal Bank of Canada's CRBU Position: Q1 2026 in Review

Royal Bank of Canada reduced its Caribou Biosciences (CRBU) stake by 83% in Q1 2026, selling an estimated $21.3K and leaving 2,462 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #6405.

Royal Bank of Canada first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.62M in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Royal Bank of Canada held 2,462 shares of Caribou Biosciences worth $5K as of Q1 2026.
  • Royal Bank of Canada sold 12,412 Caribou Biosciences shares in Q1 2026, an estimated $21.3K.
  • Caribou Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6405 holding.
  • Royal Bank of Canada first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Caribou Biosciences position peaked at $1.62M in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.